Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
24,700,055
-
Share change
-
-34,546
-
Total reported value
-
$2,164,207,829
-
Put/Call ratio
-
175%
-
Price per share
-
$87.57
-
Number of holders
-
273
-
Value change
-
-$24,341,218
-
Number of buys
-
103
-
Number of sells
-
144
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q1 2020
As of 31 Mar 2020,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
273 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,700,055 shares.
The largest 10 holders included
Capital Research Global Investors, FRANKLIN RESOURCES INC, JANUS HENDERSON GROUP PLC, CANADA PENSION PLAN INVESTMENT BOARD, Capital World Investors, CITADEL ADVISORS LLC, M&G INVESTMENT MANAGEMENT LTD, MORGAN STANLEY, FRED ALGER MANAGEMENT, LLC, and FEDERATED HERMES, INC..
This page lists
273
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.